Impact Of Waxman/Hatch Reforms On Declaratory Judgments Questioned By Judges
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal Circuit judges hearing oral arguments in Teva's lawsuit against Pfizer on a Zoloft patent express skepticism that the Medicare Modernization Act relaxed the standards for a generic company to bring a declaratory judgment action against an innovator.